What’s Changed? Key Developments in Multiple Myeloma

SurvivorNet held a collaborative conversation where opinion leaders shared what’s changed when it comes to treating multiple myeloma, the latest in new practices and protocols — and what the future may look like.

What’s very encouraging is that there continue to be new options, and therapies considered novel a few years ago are very quickly gaining traction. These can include immunotherapies such as CAR-T cells and a growing number of drug combinations.